Table 1.
Summary of clinical features and family history of patients included in the study.
| Patient # | Sex | Age at WES diagnosis | Age at onset of epilepsy | Type of seizures | Frequency of Seizures | Additional clinical features | Epilepsy/epilepsy syndrome | Family History | Anti-seizure medications used | Outcome (seizures) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 6 mo. | Neonate | Tonic spasms in clusters | Multiple per day | Encephalopathy, hypotonia | Ohtahara syndrome | No | Levetiracetam, clobazam, valproic acid, phenobarbital, zonisamide | Developmental delay (improvement of seizures) |
| 2 | F | 18 y. | 14 y. | Generalized tonic clonic, absences, myoclonic | Multiple per day | Visual hallucinations, myoclonus | Progressive myoclonus epilepsy | No | Levetiracetam, valproate, lamotrigine, clobazam, topiramate, ketogenic diet, zonisamide, phenobarbital | Dementia (partial response of seizures) |
| 3 | M | 18 mo. | 4 mo. | Infantile spasms | Multiple per day | Encephalopathy, hypotonia, abnormal ocular motility, nystagmus, extrapyramidal syndrome | Early infantile epileptic encephalopathy | No | Vigabatrin, steroids, valproic acid, pyridoxal phosphate | Developmental delay (improvement of seizures) |
| 4 | F | 17.5 y. | Neonate | Tonic spasms, myoclonic | Multiple per day | Encephalopathy, hypotonia | Early infantile epileptic encephalopathy | No | Vigabatrin, ACTH, Valproate | Developmental delay (improvement of seizures) |
| 5 | F | 2 y. | Neonate | Early spasms | Multiple per day | Encephalopathy, hypotonia | Early infantile epileptic encephalopathy | No | Vigabatrin, high dose prednisone, ketogenic diet | Developmental delay (seizure free with ketogenic diet (KD) |
| 6 | M | 18 mo. | 5.5 mo. | Generalized tonic clonic | Variable | Mild early hypotonia | Generalized | No | Phenobarbital, oxcarbazepine, levetiracetam, valproate | Normal development (partial seizure control) |
| 7 | M | 15 y. | 8 mo. | Generalized, focal to bilateral tonic clonic | High | - | Unclassified | No | Valproate, tpopiramate, lamotrigine, ketogenic diet | Developmental delay (poor outcome of seizure control) |
| 8 | M | 13 y. | 5 mo. | Focal seizures, tonic, myoclonic | High | Hypotonia | Early infantile epileptic encephalopathy | Yes (brother) | Levetiracetam, valproic acid, ketogenic diet | Developmental delay (poor outcome of seizure control) |
| 9 | M | 15 y. | 3 mo. | Non motor behavior arrest, myoclonic, atonic | High | - | Myoclonic-astatic epilepsy (Doose syndrome) | No | Valproate, levetiracetam,topiramate, lamotrigine, vigabatrin, clobazam, rufinamide, ethosuximide, ketogenic diet | Developmental delay (poor outcome of seizure control) |
| 10 | M | 5 y. | Unknown | Focal tonic spasms, myoclonic, generalized tonic clonic | Multiple per day | Macrosomia, axial hypotonia, limb hypertonia, movement disorder (dyskinesia, choreoathetosis) | Early infantile epileptic encephalopathy | No | ACTH, prednisone, valproate, topiramate | Developmental delay (poor seizure control) |
Abbreviations: mo.: months, y.: years, ACTH: adrenocorticotropic hormone.